JP2008504012A5 - - Google Patents

Download PDF

Info

Publication number
JP2008504012A5
JP2008504012A5 JP2006551550A JP2006551550A JP2008504012A5 JP 2008504012 A5 JP2008504012 A5 JP 2008504012A5 JP 2006551550 A JP2006551550 A JP 2006551550A JP 2006551550 A JP2006551550 A JP 2006551550A JP 2008504012 A5 JP2008504012 A5 JP 2008504012A5
Authority
JP
Japan
Prior art keywords
fusion protein
fsh
αfsh
βfsh
linker
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006551550A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008504012A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/003034 external-priority patent/WO2005073383A2/en
Publication of JP2008504012A publication Critical patent/JP2008504012A/ja
Publication of JP2008504012A5 publication Critical patent/JP2008504012A5/ja
Pending legal-status Critical Current

Links

JP2006551550A 2004-01-28 2005-01-27 不妊治療のためのへテロ二量体卵胞刺激ホルモン−Fc(FSH−Fc)融合タンパク質 Pending JP2008504012A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US54023604P 2004-01-28 2004-01-28
PCT/US2005/003034 WO2005073383A2 (en) 2004-01-28 2005-01-27 HETERODIMERIC FOLLICLE STIMULATING HORMONE-Fc (FSH-Fc) FUSION PROTEINS FOR THE TREATMENT OF INFERTILITY

Publications (2)

Publication Number Publication Date
JP2008504012A JP2008504012A (ja) 2008-02-14
JP2008504012A5 true JP2008504012A5 (enExample) 2008-03-27

Family

ID=34826205

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006551550A Pending JP2008504012A (ja) 2004-01-28 2005-01-27 不妊治療のためのへテロ二量体卵胞刺激ホルモン−Fc(FSH−Fc)融合タンパク質

Country Status (10)

Country Link
US (2) US7601516B2 (enExample)
EP (1) EP1711610A2 (enExample)
JP (1) JP2008504012A (enExample)
CN (1) CN1926237A (enExample)
AU (1) AU2005207960A1 (enExample)
BR (1) BRPI0507174A (enExample)
CA (1) CA2553187A1 (enExample)
IL (2) IL177049A (enExample)
NO (1) NO20063807L (enExample)
WO (1) WO2005073383A2 (enExample)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8025873B2 (en) * 2002-06-20 2011-09-27 Paladin Labs, Inc. Chimeric antigens for eliciting an immune response
US8029803B2 (en) * 2002-06-20 2011-10-04 Paladin Labs, Inc. Chimeric antigens for eliciting an immune response
US8007805B2 (en) * 2003-08-08 2011-08-30 Paladin Labs, Inc. Chimeric antigens for breaking host tolerance to foreign antigens
WO2005047337A1 (en) 2003-11-13 2005-05-26 Hanmi Pharmaceutical Co., Ltd. A pharmaceutical composition comprising an immunoglobulin fc region as a carrier
US8110665B2 (en) 2003-11-13 2012-02-07 Hanmi Holdings Co., Ltd. Pharmaceutical composition comprising an immunoglobulin FC region as a carrier
WO2005059517A2 (en) * 2003-12-16 2005-06-30 University Of Massachusetts Toll-like receptor assays
BRPI0507174A (pt) * 2004-01-28 2008-04-01 Syntonix Pharmaceuticals Inc proteìnas de fusão hormÈnio-fc (fsh-fc) heterodiméricas estimuladoras de folìculo para o tratamento da infertilidade
GB0510627D0 (en) 2005-05-25 2005-06-29 Avidex Ltd Polypeptides
JP2009511024A (ja) * 2005-10-13 2009-03-19 ヴィレックス メディカル コーポレイション 免疫応答を誘導するためのC型肝炎ウイルスポリペプチドおよびFcフラグメントを含むキメラ抗原
WO2007061896A1 (en) 2005-11-17 2007-05-31 Zogenix, Inc. Delivery of viscous formulations by needle-free injection
EP1801121A1 (en) * 2005-12-23 2007-06-27 CONARIS research institute AG Soluble gp130 molecule variants useful as a medicament
US8268347B1 (en) 2006-10-24 2012-09-18 Aradigm Corporation Dual action, inhaled formulations providing both an immediate and sustained release profile
ES2693697T3 (es) * 2007-11-30 2018-12-13 Aspenbio Pharma, Inc. Actividad de la hormona folículo estimulante equina recombinante
WO2009080764A2 (en) * 2007-12-20 2009-07-02 Abylnx N.V. Oral or nasal administration of compounds comprising amino acid sequences
AR081755A1 (es) * 2010-04-02 2012-10-17 Hanmi Holdings Co Ltd Formulacion de accion prolongada de la hormona estimuladora de los foliculos donde se usa un fragmento de inmunoglobulina, metodo de preparacion y metodo para tratar a un sujeto que sufre un trastorno reproductivo
FR2958936A1 (fr) * 2010-04-14 2011-10-21 Sanofi Aventis Proteine de fusion robo1-fc et son utilisation dans le traitement des tumeurs
JP6196163B2 (ja) 2011-03-17 2017-09-13 ミネルバ バイオテクノロジーズ コーポレーション 多能性幹細胞を作製する方法
CA2835453A1 (en) * 2011-05-09 2012-11-15 Minerva Biotechnologies Corporation Genetically engineered growth factor variants
BR112014001274A2 (pt) 2011-07-18 2017-04-18 Arts Biologics As composto de hormônio luteinizante, e, composição farmacêutica
KR101967345B1 (ko) * 2012-10-18 2019-04-09 삼성전자주식회사 안지오포이에틴-2와 인테그린 간의 결합을 저해하는 펩타이드 및 그 용도
CN103509121B (zh) 2012-11-22 2015-01-28 苏州康宁杰瑞生物科技有限公司 一种fsh融合蛋白及其制备方法和用途
WO2014152955A1 (en) 2013-03-14 2014-09-25 Regeneron Pharmaceuticals, Inc. Apelin fusion proteins and uses thereof
CN103539860B (zh) * 2013-11-01 2014-12-03 广州优联康医药科技有限公司 一种长效重组人促卵泡激素融合蛋白
CN103539862B (zh) * 2013-11-01 2015-04-01 广州联康生物科技有限公司 一种长效重组促卵泡激素及其应用
WO2015077491A1 (en) 2013-11-20 2015-05-28 Regeneron Pharmaceuticals, Inc. Aplnr modulators and uses thereof
CN104524553B (zh) * 2014-12-12 2015-07-29 薛传校 一种长效促排卵注射液
JP2018508504A (ja) * 2015-02-17 2018-03-29 ハンミ ファーマシューティカル カンパニー リミテッド 持続型インスリンまたはインスリンアナログ結合体
DK3328881T3 (da) * 2015-09-08 2019-10-07 Theripion Inc Apoa-1 fusionspolypeptider og relaterede sammensætninger og fremgangsmåder
CN105567733B (zh) * 2016-01-11 2019-04-23 佛山安普泽生物医药股份有限公司 CHO细胞表达凝血酶-Fc融合蛋白的方法
CN106046176B (zh) 2016-08-16 2019-09-10 中国药科大学 一种高活性长效降糖融合蛋白及其制备方法与医药用途
CN107082815A (zh) * 2017-06-28 2017-08-22 杭州皓阳生物技术有限公司 一种fsh‑hsa融合蛋白及其制备方法
CN107540748B (zh) * 2017-09-15 2020-07-14 北京伟杰信生物科技有限公司 长效重组猪fsh融合蛋白及其制备方法与应用
CN110305903B (zh) * 2019-07-31 2021-10-01 江苏璟泽生物医药有限公司 重组人促卵泡激素及其制备方法
CN113599503A (zh) * 2021-07-28 2021-11-05 安徽中起生物科技有限公司 一种调节卵巢功能的生物制剂及其制备方法和应用
CN118562019A (zh) * 2021-09-30 2024-08-30 宁波三生生物科技股份有限公司 重组促卵泡激素融合蛋白
CN116768979B (zh) * 2022-07-06 2025-04-29 华兰基因工程有限公司 一种重组人促卵泡生成素CTP-Fc融合蛋白及制备方法
CN115947860B (zh) * 2022-07-06 2025-04-25 华兰基因工程有限公司 一种重组人促卵泡生成素Fc融合蛋白及制备方法
WO2025140545A1 (zh) * 2023-12-28 2025-07-03 江苏众红生物工程创药研究院有限公司 新型长效人fsh与lh融合蛋白及其制备方法与应用

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4713339A (en) * 1983-01-19 1987-12-15 Genentech, Inc. Polycistronic expression vector construction
US4840896A (en) * 1983-11-02 1989-06-20 Integrated Genetics, Inc. Heteropolymeric protein
EP0721983A1 (en) * 1988-01-22 1996-07-17 ZymoGenetics, Inc. Methods of producing biologically active peptide dimers
US5338835A (en) * 1989-02-21 1994-08-16 Washington University CTP-extended form of FSH
US5225538A (en) * 1989-02-23 1993-07-06 Genentech, Inc. Lymphocyte homing receptor/immunoglobulin fusion proteins
DE59010908D1 (de) * 1989-09-12 2000-08-10 Hoffmann La Roche TNF-bindende Proteine
EP0533006A1 (en) * 1991-09-18 1993-03-24 F.Hoffmann-La Roche & Co. Aktiengesellschaft Chimaeric interleukin 5-receptor/immunoglobulin polypeptides
DK0615451T3 (da) * 1992-05-26 2006-04-24 Immunex Corp Hidtil ukendt cytokin der binder til CD30
US6485726B1 (en) * 1995-01-17 2002-11-26 The Brigham And Women's Hospital, Inc. Receptor specific transepithelial transport of therapeutics
US6030613A (en) * 1995-01-17 2000-02-29 The Brigham And Women's Hospital, Inc. Receptor specific transepithelial transport of therapeutics
US6086875A (en) * 1995-01-17 2000-07-11 The Brigham And Women's Hospital, Inc. Receptor specific transepithelial transport of immunogens
US6096871A (en) 1995-04-14 2000-08-01 Genentech, Inc. Polypeptides altered to contain an epitope from the Fc region of an IgG molecule for increased half-life
US5739277A (en) * 1995-04-14 1998-04-14 Genentech Inc. Altered polypeptides with increased half-life
BR9707589A (pt) * 1996-02-20 2000-01-04 Applied Research Systems Proteìna hìbrida, molécula de dna, vetor de expressão, célula hospedeira, composição farmacêutica e processos para produzir proteìna hìbrida e para induzir maturação folicular.
ATE279947T1 (de) 1996-03-18 2004-11-15 Univ Texas Immunglobulinähnliche domäne mit erhöhten halbwertszeiten
ATE279407T1 (de) * 1998-08-07 2004-10-15 Applied Research Systems Fsh mimetika zur behandlung von infertilität
US7081446B2 (en) * 2002-01-31 2006-07-25 The Trustees Of Columbia University In The City Of New York Long-acting follicle stimulating hormone analogues and uses thereof
WO2003077834A2 (en) * 2002-03-15 2003-09-25 The Brigham And Women's Hospital, Inc. Central airway administration for systemic delivery of therapeutics
US20040063912A1 (en) * 2002-03-15 2004-04-01 The Brigham And Women's Hospital, Inc. Central airway administration for systemic delivery of therapeutics
JP2006513139A (ja) * 2002-07-03 2006-04-20 ザ・ブリガーム・アンド・ウーメンズ・ホスピタル・インコーポレーテッド 治療薬の全身性送達のための中央部気道投与
US6936574B2 (en) * 2002-08-30 2005-08-30 Halliburton Energy Services, Inc. Process for controlling gas migration during well cementing
BRPI0507174A (pt) 2004-01-28 2008-04-01 Syntonix Pharmaceuticals Inc proteìnas de fusão hormÈnio-fc (fsh-fc) heterodiméricas estimuladoras de folìculo para o tratamento da infertilidade

Similar Documents

Publication Publication Date Title
CN102596217B (zh) 经修饰的血管活性肠肽
CN104684576B (zh) 聚乙二醇化的oxm变体
JP2022502056A5 (enExample)
ES2673317T3 (es) Proteína de fusión de hormona trófica, método de preparación y aplicación de la misma
JP7596268B2 (ja) グルカゴン、glp-1及びgip受容体の全てに活性を有する三重活性体と、インスリンとを含む薬学組成物
US8431532B2 (en) FZD8 extracellular domains and FZD8 extracellular domain fusion molecules and treatments using same
JP2020172496A (ja) 分枝状アミノ酸プローブを有するペプチド類似体
CN116059389A (zh) 胰高血糖素/glp-1/gip受体三重激动剂的长效缀合物
JP2017503509A5 (enExample)
CN104302772A (zh) 用于糖尿病治疗的蛋白、蛋白缀合物及其应用
MD3532486T2 (ro) Compuși de tirozină-tirozină peptidică ciclică cuplaţi la anticorp ca modulatori de receptori Y ai neuropeptidei
JP2018504092A5 (enExample)
MX2011009797A (es) Inhibidores peptidicos de kv1.3 potentes selectivos.
JPH05502039A (ja) 多価抗原結合性蛋白質
AU2009208063A1 (en) Human 3 relaxin
JP2014519852A5 (enExample)
JP2021531834A5 (enExample)
JP2023514452A5 (enExample)
JP2010504336A5 (enExample)
TW201446792A (zh) Nav1.7之強效及選擇性抑制劑
JP2023522799A5 (enExample)
WO2016184258A1 (zh) 一种可溶且稳定的异质二聚tcr
CN106478807A (zh) 识别mage-a3 的t 细胞受体
JP2024535925A5 (enExample)
WO2025027052A1 (en) Antibody conjugates and fusion proteins